A contrastive adversarial encoder for multi-omics data integration
PLOS One · 16.10.2025 · 20 (10) · e0333134
DOI: 10.1371/journal.pone.0333134 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.10.2025. Verfasst von Ma Yinghua und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, COMSATS University Islamabad Abbottabad Campus, Abbottabad, Pakistan. Hauptthemen laut MEDLINE: Neoplasms, Genomics, Computational Biology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umm Al-Qura University.
Abstract (Originalsprache)
Early and accurate cancer detection is crucial for effective treatment, prognosis, and the advancement of precision medicine. Analyzing omics data is vital in cancer research. While using a single type of omics data provides a limited perspective, integrating multiple omics modalities allows for a more comprehensive understanding of cancer. Current deep models struggle to achieve efficient dimensionality reduction while preserving global information and integrating multi-omics data. This often results in feature redundancy or information loss, overlooking the synergies among different modalities. This paper proposes a contrastive adversarial encoder (CAEncoder) for multi-omics data integration to address this challenge. The proposed model combines a Vision Transformer (ViT) and a CycleGAN, trained in an end-to-end contrastive manner. The ViT is the encoder, utilizing self-attention, while the CycleGAN employs adversarial learning to ensure more discriminative and invariant latent space embeddings. Contrastive adversarial training improves representation quality by preventing information loss, eliminating redundancy, and capturing the synergies among different omics modalities. To ensure contrastive adversarial training, a composite loss function is used, consisting of a weighted combination of Adversarial Loss (Hinge Loss), Cycle Consistency Loss, and Triplet Margin Loss. The Adversarial Loss and Cycle Consistency Loss provide feedback from the CycleGAN, ensuring effective adversarial learning. Meanwhile, the Triplet Margin Loss promotes contrastive learning by pulling similar samples together and pushing dissimilar samples apart in the latent space. The performance of the CAEncoder is evaluated on downstream classification tasks, including both binary and multi-class classifications of five different cancer types. The results show that the model achieved a classification accuracy of up to 93.33% and an F1 score of 92.81%, outperforming existing advanced models. These findings demonstrate the potential of our method to enhance precision medicine for cancer through improved multi-omics data integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Computer Science, COMSATS University Islamabad Abbottabad Campus, Abbottabad, Pakistan.
- Department of Software Engineering, College of Computing, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Computer Science and Information Technology, The University of Lahore, Lahore, Pakistan.
ORCID-Profile: Ma Yinghua, Yang Heng, Afnan Aldhahri, Iftikhar Ahmed Khan
Förderung
- Umm Al-Qura University
Zitieren
APA
Yinghua, M., Khan, A., Heng, Y., Gul Khan, F., Aldhahri, A., & Ahmed Khan, I. (2025). A contrastive adversarial encoder for multi-omics data integration. PLOS One, 20(10), e0333134. https://doi.org/10.1371/journal.pone.0333134
Vancouver
Yinghua M, Khan A, Heng Y, Gul Khan F, Aldhahri A, Ahmed Khan I. A contrastive adversarial encoder for multi-omics data integration. PLOS One. 2025;20(10):e0333134. doi:10.1371/journal.pone.0333134
BibTeX
@article{Yinghua2025,
author = {Yinghua, Ma and Khan, Ahmad and Heng, Yang and Gul Khan, Fiaz and Aldhahri, Afnan and Ahmed Khan, Iftikhar},
title = {A contrastive adversarial encoder for multi-omics data integration},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0333134},
doi = {10.1371/journal.pone.0333134}
}
EUVIMED